Tagged with EY

Turkey Genz Biotechnology is a biotech startup working on novel diagnostic testing solutions. Its founder and CEO, Umut Ağyüz, explains the origins of the company, the big opportunities that have arisen due to the COVID-19 pandemic, and how their solutions are a great match for low-income and rural communities.   Things…

Turkey Bıçakcılar is one of Turkey’s largest medical technology companies, selling disposables and focusing on the operating room, any hospital’s most profitable part. Souheil A. ElHakim, the company’s CEO, reflects on the company’s 62-year history, their current portfolio and explains how the new European CE mark rules change the way they…

Turkey Queisser Pharma is a German company focused on the OTC market through food supplements and medical devices. Its general manager for Turkey, Demet Eryilmaz, tells the “special” story of its major brand Doppelherz, analyzes the regulatory environment for OTC products in the country, and explains how the pandemic has transformed…

Turkey Johnson & Jonhson Medical’s general manager for Turkey, Maghreb, Iran, and Sub-Saharan Africa, Refik Öner, speaks about the big potential for his region “as the global economic centre of gravity moves east,” and reflects on his two-decade career in consumer goods. Moreover, Refik explains how money collection issues are constraining…

Turkey Getinge’s president for Central and Eastern Europe, Ahmet Eke, comments on the strategic importance of the region for the Swedish company, the evolution of healthcare infrastructure in Turkey, and how Getinge competes in emerging markets against European and American medtech players.   Like many emerging markets, monetary resources are limited…

Turkey Prof. Hasan Mandal, president of the Scientific and Technological Research Council of Turkey (TÜBİTAK), explains how the COVID-19 platform coordinated by the agency has transformed the Turkish ecosystem by bringing together 436 researchers from 49 different institutions to collaborate on 17 drug and vaccine development projects. In addition, Prof. Mandal…

Turkey While supporters of Turkey’s localization policy for pharmaceuticals implemented in 2016 applaud the changes it has brought, its opponents are awaiting a much-anticipated report by the World Trade Organization that could put an end to the policy and have global repercussions.   Five years after the launch of Turkey’s localization…

Asia-Pacific Asia has experienced a biotech boom in the past five years. In 2020, almost 50 percent of the region’s clinical trials were led by biotechs and by 2025, biotech-led clinical trials will far exceed those led by Big Pharma, according to IQVIA. However, the region’s biotechs face a myriad of…

Turkey General manager of Core Diagnostic at Abbott Turkey Yelda Ulu Colin highlights the company’s prominent role during the pandemic, including the launch of the first antibody serology testing solution just one month after the World Health Organization made an official pandemic declaration. In addition, she categorizes the government’s response to…

Turkey Turkish Cargo, the global air cargo arm of Turkish Airlines, has the world’s largest direct cargo flight network excluding express carriers which has enabled them to deliver 320 million COVID-19 vaccine doses to more than 55 countries around the world. Turhan Özen, its chief cargo officer, explains their services for…

Turkey Okan Güner of Viatris Turkey introduces the company’s sizeable footprint in the country, including local manufacturing and explains the challenges of executing an integration of two companies during the COVID-19 pandemic. Güner outlines Viatris’ role within Turkey’s Vision 2023, the opportunities for their biosimilars pipeline, and their portfolio’s role in…

Turkey Although best known for its food and beverage operations, Nestlé also has a Health Science business that generates approximately USD 3 billion annually for the Swiss conglomerate. Hanzade Yaz, General Manager of Nestlé Health Science Turkey, discusses the affiliate’s leading position in medical nutrition, portfolio expansion following recent global acquisitions…